Infectious Diseases and Vaccines

Experienced clinical research sites helping sponsors accelerate infectious disease and vaccine studies.

Accelerate Enrollment For Your Vaccine Trial

Flourish Research has the infrastructure and expertise to help sponsors rapidly enroll vaccine studies while maintaining high-quality delivery.

  • 600+ vaccine trials conducted
  • Vaccine study experience at 18 of our 30 wholly owned dedicated clinical trial sites across the country
  • Proven track record of surpassing enrollment targets
  • PBMC and PK processing capabilities
  • Overnight clinical research facilities

Talk to our experts about how we can advance your trial.

Request Feasibility
600+
Infectious Diseases and Vaccine Studies Conducted
32,000+
Participants Enrolled

Strong Infectious Disease and Vaccine Indication Experience Across Our Network

  • C. difficile
  • Chikungunya
  • COVID-19
  • Crimean-Congo hemorrhagic fever virus (CCHFV)
  • Cytomegalovirus (CMV)
  • Herpes zoster (Shingles)
  • HPV
  • Influenza (adult and pediatric)
  • Malaria
  • Meningitis
  • Meningococcal infection
  • MMR vaccine
  • Norovirus
  • Pneumococcal
  • Pneumonia
  • Respiratory syncytial virus (RSV)
  • TDAP
  • Travelers’ diarrhea
  • UTI

Recent Vaccine Enrollment Successes

Phase I Epilepsy Vaccine Trial

100% of patients randomized on time.

Phase III RSV Vaccine (Double-blind) Study

Randomized 340+ patients, achieving 165% of enrollment target within the study timeline.

Phase III Norovirus Vaccine (placebo-controlled) Study

Achieved 198% of enrollment target on schedule.

Onsite PBMC Processing for Greater Sample Efficiency

Peripheral blood mononuclear cells (PBMC) capabilities are critical in assessing immune responses in vaccine clinical trials.

Flourish Research offers in-house PBMC labs to for greater efficiency across our network.

  • High-yield, high-viability cryopreserved (PBMC) cells
  • High-volume PBMC processing – up to 20 samples per day
  • Onsite processing eliminates the need for sample transport
  • Network-wide SOPs and quality control

Best-in-class facilities and processes:

  • Temperature-controlled labs
  • Isolation using Ficoll/CPT and/or other isolation techniques
  • Class II A2 biosafety cabinets
  • Fluorescent staining & image analysis
  • Two-step cryopreservation process
  • Long-term storage in vapor phase of liquid nitrogen at -135°C

Vaccine Experienced PIs

Manish Jain M.D.

Principal Investigator and VP of Physician Engagement, Flourish Research – Chicago

Helen L. Stacey M.D., MPH

Principal Investigator, Flourish Research – Walnut Creek

Request A Feasibility

Connect with our team to see how quickly we can begin recruiting for your study.

Name(Required)
Email(Required)
Please let us know any details about your study that would be helpful in getting you connected with the right experts.

Flourish Research News

Stay current with the latest clinical trial news and learn how Flourish Research is supporting the advancement of life-changing therapeutics.